Literature DB >> 3332741

Abnormal fetal cerebral blood flow velocity waveforms as a sign of an aneurysm of the vein of Galen.

G Rizzo1, D Arduini, C Colosimo, M R Boccolini, S Mancuso.   

Abstract

A cerebral midline cystic lesion was detected by real-time ultrasound in utero in the absence of other congenital abnormalities. Pulsed Doppler ultrasound assessment of fetal circulation demonstrated normal peripheral and intracardiac hemodynamics associated with decreased cerebral vascular resistance. Furthermore, a markedly turbulent flow pattern was evidenced within the cerebral lesion. The presence of a cerebral arteriovenous malformation with an aneurysm of the vein of Galen was suggested and the provisional diagnosis was later confirmed by computed tomography and carotid angiography performed after birth.

Entities:  

Mesh:

Year:  1987        PMID: 3332741     DOI: 10.1159/000263287

Source DB:  PubMed          Journal:  Fetal Ther        ISSN: 0257-2788


  4 in total

1.  Prognosis of antenatally diagnosed vein of Galen aneurysmal malformations.

Authors:  G Rodesch; F Hui; H Alvarez; A Tanaka; P Lasjaunias
Journal:  Childs Nerv Syst       Date:  1994-03       Impact factor: 1.475

2.  Successful treatment of neonatal aneurysmal dilatation of the vein of Galen: the role of prenatal diagnosis and trans-arterial embolization.

Authors:  Y Yamashita; T Abe; N Ohara; T Maruoka; O Toyoda; O Inoue; K Kojima; H Kato
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

Review 3.  Four-dimensional MRI flow examinations in cerebral and extracerebral vessels - ready for clinical routine?

Authors:  Susanne Schnell; Can Wu; Sameer A Ansari
Journal:  Curr Opin Neurol       Date:  2016-08       Impact factor: 5.710

4.  Age-Related Changes of Normal Cerebral and Cardiac Blood Flow in Children and Adults Aged 7 Months to 61 Years.

Authors:  Can Wu; Amir R Honarmand; Susanne Schnell; Ryan Kuhn; Samantha E Schoeneman; Sameer A Ansari; James Carr; Michael Markl; Ali Shaibani
Journal:  J Am Heart Assoc       Date:  2016-01-04       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.